
TY  - JOUR
AU  - Tovar-y-Romo, Luis B.
AU  - Penagos-Puig, Andrés
AU  - Ramírez-Jarquín, Josué O.
TI  - Endogenous recovery after brain damage: molecular mechanisms that balance neuronal life/death fate
JO  - Journal of Neurochemistry
JA  - J. Neurochem.
VL  - 136
IS  - 1
SN  - 0022-3042
UR  - https://doi.org/10.1111/jnc.13362
DO  - doi:10.1111/jnc.13362
SP  - 13
EP  - 27
KW  - neurodegeneration
KW  - neuroinflammation
KW  - neuronal death
KW  - neuronal survival
KW  - stroke
KW  - trophic factors
PY  - 2016
AB  - Abstract Neuronal survival depends on multiple factors that comprise a well-fueled energy metabolism, trophic input, clearance of toxic substances, appropriate redox environment, integrity of blood?brain barrier, suppression of programmed cell death pathways and cell cycle arrest. Disturbances of brain homeostasis lead to acute or chronic alterations that might ultimately cause neuronal death with consequent impairment of neurological function. Although we understand most of these processes well when they occur independently from one another, we still lack a clear grasp of the concerted cellular and molecular mechanisms activated upon neuronal damage that intervene in protecting damaged neurons from death. In this review, we summarize a handful of endogenously activated mechanisms that balance molecular cues so as to determine whether neurons recover from injury or die. We center our discussion on mechanisms that have been identified to participate in stroke, although we consider different scenarios of chronic neurodegeneration as well. We discuss two central processes that are involved in endogenous repair and that, when not regulated, could lead to tissue damage, namely, trophic support and neuroinflammation. We emphasize the need to construct integrated models of neuronal degeneration and survival that, in the end, converge in neuronal fate after injury. Under neurodegenerative conditions, endogenously activated mechanisms balance out molecular cues that determine whether neurons contend toxicity or die. Many processes involved in endogenous repair may as well lead to tissue damage depending on the strength of stimuli. Signaling mediated by trophic factors and neuroinflammation are examples of these processes as they regulate different mechanisms that mediate neuronal demise including necrosis, apoptosis, necroptosis, pyroptosis and autophagy. In this review, we discuss recent findings on balanced regulation and their involvement in neuronal death.
ER  - 

AU  - Valli, Victor E.
AU  - Bienzle, Dorothee
AU  - Meuten, Donald J.
C7  - pp. 203-321
TI  - Tumors of the Hemolymphatic System
SN  - 9780813821795
UR  - https://doi.org/10.1002/9781119181200.ch7
DO  - doi:10.1002/9781119181200.ch7
SP  - 203-321
KW  - bone marrow
KW  - cytological characteristics
KW  - hemolymphatic system
KW  - lymphoblastic tumors
KW  - molecular diagnostic tests
KW  - myeloid leukemias
KW  - neoplastic cells
KW  - veterinary medicine
PY  - 2016
AB  - Summary The two general groups for tumors of the hemolymphatic system are lymphoid (lymphoma and leukemia) and myeloid leukemias. The tumors in each can be characterized by their anatomic distribution in the body, histologic distribution within hemolymphatic organs, morphology of cells, immunophenotype, cytopenias, and, when known, their biologic behavior and molecular characteristics. Lymphoblastic tumors are some of the most aggressive neoplasms in veterinary medicine with survival times measured in weeks to months. Lymphomas arise in lymphoid tissues outside of the bone marrow and leukemias arise in bone marrow or spleen. Classification of lymphomas has progressed through criteria largely related to cytological characteristics (Kiel) to one based on distinct diseases encompassing the total information related to that neoplasm. The Kiel and WHO/REAL classifications use multiple parameters to subdivide lymphomas into many diagnoses. Molecular techniques complement these classifications and additionally further subdivide lymphomas and leukemias, demonstrating how heterogeneous phenotypically similar tumors are.
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 48
IS  - S36
SN  - 9780813821795
UR  - https://doi.org/10.1002/ppul.22898
DO  - doi:10.1002/ppul.22898
SP  - 207
EP  - 453
PY  - 2013
ER  - 

TY  - JOUR
AU  - HASSELL, THOMAS M.
TI  - Tissues and cells of the periodontium
JO  - Periodontology 2000
VL  - 3
IS  - 1
SN  - 9780813821795
UR  - https://doi.org/10.1111/j.1600-0757.1993.tb00230.x
DO  - doi:10.1111/j.1600-0757.1993.tb00230.x
SP  - 9
EP  - 38
PY  - 1993
ER  - 

TY  - JOUR
AU  - Mercader, P
AU  - Rodenas, JM
AU  - Peña, A
AU  - Mascaro Jr, JM
TI  - Fatal Pseudomona pneumonia following rituximab therapy in a patient with epidermolysis bullosa acquisita
JO  - Journal of the European Academy of Dermatology and Venereology
VL  - 21
IS  - 8
SN  - 9780813821795
UR  - https://doi.org/10.1111/j.1468-3083.2006.02127.x
DO  - doi:10.1111/j.1468-3083.2006.02127.x
SP  - 1141
EP  - 1142
PY  - 2007
ER  - 

TY  - JOUR
TI  - Oral presentations
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 98
IS  - S3
SN  - 9780813821795
UR  - https://doi.org/10.1002/bjs.7525
DO  - doi:10.1002/bjs.7525
SP  - 1
EP  - 79
PY  - 2011
AB  - Abstract The International Surgical Congress of the Association of Surgeons of Great Britain and Ireland takes place this year in Bournemouth, UK (11?13 May 2011). Copyright ? 2011 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - Abstracts LB PDS
JO  - Allergy
JA  - Allergy
VL  - 74
IS  - S106
SN  - 9780813821795
UR  - https://doi.org/10.1111/all.13960
DO  - doi:10.1111/all.13960
SP  - 333
EP  - 376
PY  - 2019
ER  - 

TY  - JOUR
TI  - Proceedings of the Annual Scientific Meeting of the Australasian Society for Infectious Diseases, 2003
JO  - Internal Medicine Journal
VL  - 33
IS  - 9‐10
SN  - 9780813821795
UR  - https://doi.org/10.1046/j.1445-5994.2003.00002.x
DO  - doi:10.1046/j.1445-5994.2003.00002.x
SP  - A57
EP  - A70
PY  - 2003
ER  - 

TY  - JOUR
TI  - 24th Clinical Congress Abstracts
JO  - Journal of Parenteral and Enteral Nutrition
JA  - Journal of Parenteral and Enteral Nutrition
VL  - 24
IS  - 1
SN  - 9780813821795
UR  - https://doi.org/10.1177/014860710002400111
DO  - doi:10.1177/014860710002400111
SP  - S1
EP  - S30
PY  - 2000
ER  - 

TY  - JOUR
TI  - British Society for Investigative Dermatology Annual Meeting, Nottingham, 20–21 September 1993
JO  - British Journal of Dermatology
VL  - 129
IS  - 4
SN  - 9780813821795
UR  - https://doi.org/10.1111/j.1365-2133.1993.tb03182.x
DO  - doi:10.1111/j.1365-2133.1993.tb03182.x
SP  - 477
EP  - 497
PY  - 1993
ER  - 

TY  - JOUR
TI  - The cellular and molecular regulation of the acute inflammatory response
JO  - Journal of Cellular Biochemistry
JA  - J. Cell. Biochem.
VL  - 56
IS  - S18B
SN  - 9780813821795
UR  - https://doi.org/10.1002/jcb.240560607
DO  - doi:10.1002/jcb.240560607
SP  - 309
EP  - 330
PY  - 1994
ER  - 

TY  - JOUR
AU  - Csaszar, Elizabeth
AU  - Cohen, Sandra
AU  - Zandstra, Peter W.
TI  - Blood stem cell products: Toward sustainable benchmarks for clinical translation
JO  - BioEssays
JA  - Bioessays
VL  - 35
IS  - 3
SN  - 9780813821795
UR  - https://doi.org/10.1002/bies.201200118
DO  - doi:10.1002/bies.201200118
SP  - 201
EP  - 210
KW  - bioengineering
KW  - hematopoietic stem cell transplantation
KW  - in vitro expansion
KW  - umbilical cord blood
PY  - 2013
AB  - Abstract Robust ex vivo expansion of umbilical cord blood (UCB) derived hematopoietic stem and progenitor cells (HSPCs) should enable the widespread use of UCB as a source of cells to treat hematologic and immune diseases. Novel approaches for HSPC expansion have recently been developed, setting the stage for the production of blood stem cell derived products that fulfill our current best known criteria of clinical relevance. Translating these technologies into clinical use requires bioengineering strategies to overcome challenges of scale-up, reproducibility, and product quality assurance. Clinical-scale implementation should also define criteria and targets for cost-effective cell manufacturing. As production strategies become more effective, new opportunities in the therapeutic use of ex vivo expanded hematopoietic cell products will emerge. Herein we examine key technological milestones that need to be met in order to move ex vivo expanded HSPC therapies from the bench-top to the bedside in a robust and reliable manner.
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Immunology
VL  - 135
IS  - s1
SN  - 9780813821795
UR  - https://doi.org/10.1111/j.1365-2567.2011.03534.x
DO  - doi:10.1111/j.1365-2567.2011.03534.x
SP  - 52
EP  - 212
PY  - 2011
ER  - 

TY  - JOUR
TI  - Miscelloneous infections in cancer patients
JO  - Clinical Microbiology and Infection
VL  - 3
IS  - s2
SN  - 9780813821795
UR  - https://doi.org/10.1111/j.1469-0691.1997.tb01010.x
DO  - doi:10.1111/j.1469-0691.1997.tb01010.x
SP  - 337
EP  - 340
PY  - 1997
ER  - 

TY  - JOUR
TI  - Burns and Plastic Surgery Section
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 98
IS  - 6
SN  - 9780813821795
UR  - https://doi.org/10.1002/bjs.7508
DO  - doi:10.1002/bjs.7508
SP  - e11
EP  - e17
PY  - 2011
AB  - Abstract The BBA joined the Society of Academic and Research Surgery for their Annual Meeting on 6 January 2010 at the Royal Free Hospital. Copyright ? 2011 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - Abstract Presentations from the AABB Annual Meeting Boston, MA, October 13–16, 2018
JO  - Transfusion
JA  - Transfusion
VL  - 58
IS  - S2
SN  - 9780813821795
UR  - https://doi.org/10.1111/trf.14903
DO  - doi:10.1111/trf.14903
SP  - 6A
EP  - 254A
PY  - 2018
ER  - 

AU  - Wetzel, Gayle Delmonte
C7  - pp. 125-188
TI  - Medical Applications of Recombinant Proteins in Humans and Animals
SN  - 9783527257621
UR  - https://doi.org/10.1002/9783527620999.ch5d
DO  - doi:10.1002/9783527620999.ch5d
SP  - 125-188
KW  - recombinant
KW  - therapeutic
KW  - infarction
KW  - mortality
KW  - transcription
PY  - 2018
AB  - Summary The prelims comprise: Introduction Human Medical Applications of Recombinant Proteins Applications in Animals Concluding Remarks
ER  - 

TY  - JOUR
TI  - The Abstract
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 84
IS  - S1
SN  - 9783527257621
UR  - https://doi.org/10.1002/bjs.1800841302
DO  - doi:10.1002/bjs.1800841302
SP  - 1
EP  - 71
PY  - 1997
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - International Journal of Urology
JA  - Int. J. Urol.
VL  - 23
IS  - S1
SN  - 9783527257621
UR  - https://doi.org/10.1111/iju.13149
DO  - doi:10.1111/iju.13149
SP  - 1
EP  - 142
PY  - 2016
ER  - 

AU  - Slater, J. D.
C7  - pp. 249-283
TI  - Medical Nursing
SN  - 9780632057276
UR  - https://doi.org/10.1002/9780470690543.ch14
DO  - doi:10.1002/9780470690543.ch14
SP  - 249-283
KW  - infectious diseases
KW  - respiratory system diseases
KW  - intramuscular injection
KW  - circulatory system diseases
KW  - equine influenza virus
PY  - 2016
AB  - Summary This chapter contains section titled: Infectious and Non-Infectious Disease Infectious and Contagious Disease Respiratory System Diseases Circulatory System Diseases Haematopoietic System Diseases Alimentary System Diseases Renal System Diseases Nervous System Diseases Cutaneous System Diseases Eye Diseases Muscular Diseases Foal Diseases Endocrine System Diseases Further Reading
ER  - 
